Modulation of HMGB1, PRF1, TRAIL, and M-CSF after TARGIT-IORT in breast-conserving surgery: defining a unique acute immune landscape.
Saved in:
| Title: | Modulation of HMGB1, PRF1, TRAIL, and M-CSF after TARGIT-IORT in breast-conserving surgery: defining a unique acute immune landscape. |
|---|---|
| Authors: | Ramdas Y; Radiation Oncology, Corewell Health William Beaumont University, Royal Oak, 3601 W 13 Mile Rd, Royal Oak, MI, 48073, USA. yastiraramdss@gmail.com.; Department of Immunology, University of Pretoria, Lynnwood Rd, Hatfield, Pretoria, 0002, South Africa. yastiraramdss@gmail.com., Worsley C; Department of Immunology, University of Pretoria, Lynnwood Rd, Hatfield, Pretoria, 0002, South Africa.; National Health Laboratory, Sandrigham, Johannesburg, 2017, South Africa., Meyer PW; Department of Immunology, University of Pretoria, Lynnwood Rd, Hatfield, Pretoria, 0002, South Africa.; National Health Laboratory, Sandrigham, Johannesburg, 2017, South Africa., Benn CA; The Breast Care Unit, NetCare Milpark, 9 Guild Road, Parktown, Johannesburg, 2000, South Africa. |
| Source: | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2026 Apr 17. Date of Electronic Publication: 2026 Apr 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
